
### [MONDO:0018307](http://purl.obolibrary.org/obo/MONDO_0018307)
**Label:** neurodegeneration with brain iron accumulation

**Subclasses:** [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0013674](http://purl.obolibrary.org/obo/MONDO_0013674) (neurodegeneration with brain iron accumulation 4), [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0013060](http://purl.obolibrary.org/obo/MONDO_0013060) (autosomal recessive Parkinson disease 14), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0014290](http://purl.obolibrary.org/obo/MONDO_0014290) (neurodegeneration with brain iron accumulation 6), [MONDO:0009419](http://purl.obolibrary.org/obo/MONDO_0009419) (Woodhouse-Sakati syndrome), [MONDO:0011706](http://purl.obolibrary.org/obo/MONDO_0011706) (Kufor-Rakeb syndrome), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0011638](http://purl.obolibrary.org/obo/MONDO_0011638) (neurodegeneration with brain iron accumulation 3), [MONDO:0017809](http://purl.obolibrary.org/obo/MONDO_0017809) (parkinsonism due to ATP13A2 deficiency), [MONDO:0010476](http://purl.obolibrary.org/obo/MONDO_0010476) (neurodegeneration with brain iron accumulation 5), [MONDO:0012444](http://purl.obolibrary.org/obo/MONDO_0012444) (neurodegeneration with brain iron accumulation 2b), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0011426](http://purl.obolibrary.org/obo/MONDO_0011426) (aceruloplasminemia), [MONDO:0017999](http://purl.obolibrary.org/obo/MONDO_0017999) (fatty acid hydroxylase-associated neurodegeneration), 

**Corr. equiv. classes:** [OMIM:241080](http://purl.obolibrary.org/obo/OMIM_241080), [Orphanet:157846](http://www.orpha.net/ORDO/Orphanet_157846), [Orphanet:329308](http://www.orpha.net/ORDO/Orphanet_329308), [Orphanet:216866](http://www.orpha.net/ORDO/Orphanet_216866), [Orphanet:289560](http://www.orpha.net/ORDO/Orphanet_289560), [Orphanet:306674](http://www.orpha.net/ORDO/Orphanet_306674), [Orphanet:329303](http://www.orpha.net/ORDO/Orphanet_329303), [OMIM:615643](http://purl.obolibrary.org/obo/OMIM_615643), [Orphanet:48818](http://www.orpha.net/ORDO/Orphanet_48818), [OMIM:614298](http://purl.obolibrary.org/obo/OMIM_614298), [OMIM:256600](http://purl.obolibrary.org/obo/OMIM_256600), [Orphanet:329284](http://www.orpha.net/ORDO/Orphanet_329284), [OMIM:612953](http://purl.obolibrary.org/obo/OMIM_612953), [OMIM:610217](http://purl.obolibrary.org/obo/OMIM_610217), [Orphanet:314632](http://www.orpha.net/ORDO/Orphanet_314632), [Orphanet:397725](http://www.orpha.net/ORDO/Orphanet_397725), [OMIM:606159](http://purl.obolibrary.org/obo/OMIM_606159), [Orphanet:199351](http://www.orpha.net/ORDO/Orphanet_199351), [Orphanet:216873](http://www.orpha.net/ORDO/Orphanet_216873), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [OMIM:300894](http://purl.obolibrary.org/obo/OMIM_300894), [OMIM:604290](http://purl.obolibrary.org/obo/OMIM_604290), [OMIM:606693](http://purl.obolibrary.org/obo/OMIM_606693), [Orphanet:3464](http://www.orpha.net/ORDO/Orphanet_3464), [Orphanet:35069](http://www.orpha.net/ORDO/Orphanet_35069), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), 

**Class expressions from DL-Learner:**

- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0001332](http://purl.obolibrary.org/obo/HP_0001332) (Dystonia) 63.46%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0004305](http://purl.obolibrary.org/obo/HP_0004305) (Involuntary movements) 60.23%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) 57.56%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 57.56%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 57.56%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 57.56%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0002167](http://purl.obolibrary.org/obo/HP_0002167) (Neurological speech impairment) 57.56%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) 57.56%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) 57.56%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002067](http://purl.obolibrary.org/obo/HP_0002067) (Bradykinesia) 55.29%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002067](http://purl.obolibrary.org/obo/HP_0002067) (Bradykinesia) 55.29%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002067](http://purl.obolibrary.org/obo/HP_0002067) (Bradykinesia) 53.35%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0001300](http://purl.obolibrary.org/obo/HP_0001300) (Parkinsonism) 53.35%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002067](http://purl.obolibrary.org/obo/HP_0002067) (Bradykinesia) 53.35%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002067](http://purl.obolibrary.org/obo/HP_0002067) (Bradykinesia) and [HP:0002167](http://purl.obolibrary.org/obo/HP_0002167) (Neurological speech impairment) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 53.35%


